For a Copy of the Complete Reserach Paper Contact Kelly on LinkedIn
EXECUTIVE LEADERSHIP DECISION DASHBOARD
The Radiology Site-Neutral Shock
Translate the proposed Medicare payment realignment into local financial exposure, capacity requirements, access safeguards, and board-level action.
THE DECISION IN ONE VIEW
A concentrated payment shock with systemwide consequences
The direct proposal targets defined noncontrast imaging at excepted off-campus PO-billing departments. The strategic effects can spread through operations, access, and market structure.
Direct scope is narrow
Excepted off-campus PO departments and affected imaging without contrast are the direct treatment group.
Claim loss can be severe
The PFS proxy is approximately 31% to 54% of OPPS, but enterprise exposure depends on volume and payer mix.
Patient savings are immediate
CMS estimates $70 million in lower beneficiary coinsurance if the proposal is finalized and implemented.
Independent centers gain position
The differential narrows, but independent centers receive no automatic rate increase and may face capacity constraints.
Hospital response shapes access
Redesign, relocation, partnership, cross-subsidy, or closure create different patient and market consequences.
Outcomes must be measured
Savings alone cannot establish effects on wait time, travel, completion, safety, equity, or concentration.
Hospital radiology
Model technical revenue, contribution margin, downstream value, and site-specific strategic purpose.
Independent imaging
Test whether capacity, staffing, contracts, authorization, and clinical capability can absorb migrated volume.
Patients
Measure liability together with travel, wait, network access, diagnostic completion, and follow-up.
SCOPE ENGINE
Determine whether a local scenario is directly affected
The engine distinguishes affected, exempt, already site neutral, and out-of-scope scenarios. It does not infer policy exposure from a facility name alone.
| Site of care | Current technical payment | Direct proposal effect | Strategic exposure |
|---|---|---|---|
| On-campus HOPD | OPPS | No direct reduction | Potential inflow, congestion, and future expansion risk |
| Excepted off-campus PBD, PO | Generally full OPPS | Direct PFS-equivalent rate | Highest where affected volume and Medicare share are material |
| Nonexcepted off-campus PBD, PN | PFS-equivalent relativity | Little incremental effect | Operating-model benchmark and potential destination |
| Independent office or IDTF | PFS technical component | No rate increase | Possible volume gain constrained by capacity and contracting |
| Radiologist professional component | PFS or contract methodology | Not principal target | Reading volume, coverage, worksite, and contracts may shift |
Included in the listed proposal
Standard imaging APCs 5521-5524 and composite APCs 8004, 8005, and 8007 when furnished at an affected PO-billing excepted off-campus PBD.
Requires separate analysis
Contrast composite APCs 8006 and 8008, emergency and inpatient imaging, nuclear medicine, interventional radiology, and professional interpretation.
FINANCIAL SCENARIO MODEL
Translate the rate differential into local exposure
All outputs below are illustrative user calculations. They are not CMS forecasts, legal advice, or a substitute for final local payment files and cost accounting.
CALCULATED OUTPUTS
REVENUE BRIDGE
Current revenue compared with modeled revenue
| Current revenue | $2,040,000 |
|---|---|
| Modeled revenue | $816,000 |
| Direct loss | $1,224,000 |
SENSITIVITY
Affected revenue share × payment reduction
Cells show the estimated reduction in total facility revenue before behavior. Select a cell to compare it with the current scenario.
| Output | Formula | Interpretation |
|---|---|---|
| Direct loss | Volume × (current payment – modeled payment) | Gross technical revenue reduction before behavior |
| Patient savings | Direct loss × liability share | Simplified patient liability reduction |
| Rate-only volume | Current payment ÷ modeled payment | Gross revenue replacement with costs ignored |
| Cost-adjusted volume | V0 × (P0 – Cv) ÷ (P1 – Cv) | Volume required to preserve contribution margin |
CAPACITY AND ACCESS GUARDRAILS
Test whether lower payment can be absorbed without creating an access gap
The financial model and access tier remain separate. A high revenue loss does not justify a response that creates critical access risk.
THE PATIENT PATHWAY
Price is only one part of access.
Referral, authorization, scheduling, travel, examination, interpretation, and follow-up must remain connected.
CAPACITY RESULT
| Tier | Local conditions | Operating implication |
|---|---|---|
| Low | At least two capable alternatives, sufficient staffed capacity, modest travel change, broad network access | Standard transition monitoring |
| Moderate | Alternative capacity exists, but waits, authorization, transportation, or specialty capability are constrained | Capacity commitment and patient navigation |
| High | One alternative, material travel, staffing fragility, capacity gap, or high complexity needs | Formal mitigation before site or hour reduction |
| Critical | No timely clinically capable alternative or closure would create a diagnostic-access gap | Preserve capacity, seek exception or subsidy, and trigger review |
BOARD AND OPERATING RESPONSE
Convert exposure into sequenced action with guardrails
Irreversible site decisions should pause until finance, radiology, compliance, medical leadership, and patient-access owners validate the same claim-level facts.
Establish factual exposure
Inventory sites, modifiers, claims, allowed amounts, cost, and beneficiary liability.
Test operating options
Evaluate capacity, cost, access, clinical criteria, contracts, and capital alternatives.
Execute with guardrails
Set maximum wait, travel, cancellation, repeat, and workforce thresholds before action.
CURRENT MODEL SIGNALS
Decision conditions
ACTION PRIORITIES
What leadership should do next
- 01Validate PO exposure
Reconcile claims, APC assignments, and allowed amounts.
- 02Build capacity mitigation
Modeled migrated volume exceeds available scanner hours.
- 03Protect access
Set travel, wait, and completion guardrails before changing hours or sites.
| Domain | Core metric | Guardrail | Cadence | Current model signal |
|---|---|---|---|---|
| Finance | Revenue at risk and contribution variance | No unexplained variance above 5% of modeled loss | Monthly | Validate exposure |
| Operations | Completed exams per staffed scanner hour | No increase in repeat or failed examinations | Weekly | Capacity watch |
| Access | Order-to-completion days and travel time | No material deterioration for high-risk communities | Monthly | Mitigation needed |
| Patient | Estimated liability and cancellation rate | Savings not offset by higher abandonment | Monthly | Measure prospectively |
| Workforce | Vacancy, overtime, turnover, workload | No unsafe staffing or sustained overtime spike | Monthly | Staffing model needed |
| Market | Share by site type and alternative capacity | Review closures, acquisitions, or concentration increases | Quarterly | Baseline required |
Retain and redesign
Lower cost per slot while preserving strategically important access and volume.
Best when contribution can remain positive and local access matters.Shift to on-campus
Preserve payment under the narrow proposal but test congestion, travel, and policy-intent risks.
Requires transparent access monitoring.Convert or restructure
Align enrollment, contracts, governance, and operating cost with PFS-equivalent economics.
Potentially improves price clarity.Partner, joint venture, or sell
Share capital and operational risk while monitoring referral control and concentration.
Can support survival or increase market power.Cross-subsidize
Preserve mission access through an explicit, board-approved subsidy with performance guardrails.
Use when access risk exceeds economic tolerance.Close or reduce hours
Stop negative contribution only after clinically capable alternatives and patient pathways are verified.
Highest access-risk option.No patient information is collected. Calculations remain in this browser.
REPORT FIGURES AND SOURCE LOGIC
Evidence library
Each figure retains its original interpretation and source boundary. Select any figure to review it at full size.
OFFICIAL POLICY
CMS and Federal Register
Defines legal status, affected settings, modifiers, APC scope, proposed payment method, exemptions, and official savings estimates.
Open the CMS fact sheetFEDERAL OPTIONS
MedPAC and CBO
Provides policy design, distributional analysis, and broader fiscal alternatives that must not be mistaken for the current proposal.
Open the CBO optionPEER-REVIEWED EVIDENCE
Health Affairs and HSR
Examines site-based incentives, policy reach, hospital effects, commercial imaging price variation, and integration.
Open Lou et al. (2025)ILLUSTRATIVE ANALYSIS
Author scenario model
Translates local volume, allowed amounts, costs, payer mix, and capacity assumptions into decision ranges. It is not a forecast.
Research integrity and model limitations
- The 2027 imaging policy is proposed and may change.
- The research uses no patient-level claims and is not a formal CMS or CBO budget score.
- Local results require claim-level modifiers, final payment files, cost accounting, contracts, and operational validation.
- Access and market effects are contingent and must be measured after implementation.
- This dashboard is educational and does not constitute legal, reimbursement, accounting, or investment advice.
Prepared by Kelly Emrick, DHSc, PhD, MBA, BSRT(ARRT)R. Evidence and policy status reviewed through July 31, 2026.